呼吸

间质性肺疾病患者激烈的有氧运动训练后易疲劳性的变化

作者:高翠歌 编译 来源:金宝搏网站登录技巧 日期:2016-05-18
导读

         间质性肺疾病患者激烈的有氧运动训练后易疲劳性的变化

Changes in fatigability following intense aerobic exercise training in patients with interstitial lung disease

Randall E. Keysere, Eric J. Christensen, Lisa M.K. Chin, Joshua G. Woolstenhulme, Bart Drinkard, Anne Quinn, Gerilynn Connors, Nargues A. Weir, Steven D. Nathan, Leighton E. Chan

Objective

 

To determine if, in patients with interstitial lung disease (ILD), fatigue might be lessened after vigorous aerobic exercise.

Methods

 

13 physically inactive patients (5 men and 8 women; age 57.2 ± 9.1 years, BMI 28.2 ± 4.6 kgm−2) with ILD of heterogeneous etiology and able to walk on a motor driven treadmill without physical limitation were enrolled. Subjects underwent cardiopulmonary exercise (CPET) and 6-min walk (6MWT) tests and completed Fatigue Severity Scale and Human Activity Profile questionnaires before and after an aerobic exercise-training regimen. The training regimen required participation in at least 24 of 30 prescribed aerobic exercise training sessions at a target heart rate of 70–80% of the heart rate reserve, 30 min per session, 3 times per week for 10 weeks.

Results

 

After training, a 55% (p < 0.001) increase in time to anaerobic threshold on the CPET, and an 11% (p = 0.045) reduction in performance fatigability index (PFI), calculated from the performance on the 6MWT were observed. Distance walked on the 6MWT (6MWD) increased by 49.7 ± 46.9 m (p = 0.002). Significant improvements in scores on the Fatigue Severity Scale (p = 0.046) and Human Activity Profile (AAS p = 0.024; MAS p = 0.029) were also observed. No adverse events related to the training regimen were noted.

Conclusion

 

After training, the decrease in fatigability appeared to result in increased 6MWD and was associated with physical activity. Since significant declines in 6MWD may be a marker for impending mortality in ILD, a better understanding of the etiological state of fatigue in patients with ILD and its reversal might provide fundamental insight into disease progression and even survival. [ClinicalTrials.gov identifier NCT00678821].

respiratory medicine

April 2015Volume 109, Issue 4, Pages 517–525

DOI: http://dx.doi.org/10.1016/j.rmed.2015.01.021 |

分享:

相关文章

评论

我要跟帖
发表
回复 小鸭梨
发表

copyright©金宝搏网站登录技巧 版权所有,未经许可不得复制、转载或镜像

京ICP证120392号  京公网安备110105007198  京ICP备10215607号-1  (京)网药械信息备字(2022)第00160号
//站内统计 //百度统计 //谷歌统计 //站长统计
*我要反馈: 姓    名: 邮    箱:
Baidu
map